The pediatric sepsis biomarker risk model

INTRODUCTION: The intrinsic heterogeneity of clinical septic shock is a major challenge. For clinical trials, individual patient management, and quality improvement efforts, it is unclear which patients are least likely to survive and thus benefit from alternative treatment approaches. A robust risk...

詳細記述

保存先:
書誌詳細
主要な著者: Wong, Hector R, Salisbury, Shelia, Xiao, Qiang, Cvijanovich, Natalie Z, Hall, Mark, Allen, Geoffrey L, Thomas, Neal J, Freishtat, Robert J, Anas, Nick, Meyer, Keith, Checchia, Paul A, Lin, Richard, Shanley, Thomas P, Bigham, Michael T, Sen, Anita, Nowak, Jeffrey, Quasney, Michael, Henricksen, Jared W, Chopra, Arun, Banschbach, Sharon, Beckman, Eileen, Harmon, Kelli, Lahni, Patrick, Lindsell, Christopher J
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2012
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3682273/
https://ncbi.nlm.nih.gov/pubmed/23025259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc11652
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料